EUVIMEDEUVIMED entdecken
Crossref

Synthesis and analytical characterization of 1‐(2‐thienoyl)‐6‐allyl‐nor‐ d ‐lysergic acid diethylamide (1T‐AL‐LAD)

Yuki Okada iD, Hiroki Segawa iD, Tadashi Yamamuro, Kenji Kuwayama iD, Kenji Tsujikawa iD, Tatsuyuki Kanamori iD, Yuko T Iwata

Drug Testing and Analysis · 2025

DOI: 10.1002/dta.3747 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug Testing and Analysis, 2025. Verfasst von Yuki Okada und 6 weiteren Autor:innen. Beteiligte Einrichtung: Third Department of Forensic Science, National Research Institute of Police Science, Kashiwa, Chiba, Japan. Hauptthemen laut MEDLINE: Lysergic Acid Diethylamide, Illicit Drugs, Hallucinogens. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 27 Literaturangaben. Gefördert von: Japan Society for the Promotion of Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Lysergic acid diethylamide (LSD) analogs have emerged as new psychoactive substances (NPS) since the mid‐2010s, and new compounds continue to emerge for recreational use. Since the end of 2023, “1D‐AL‐LAD” appeared on X (formerly Twitter) and other websites. As for the compound “1D‐LSD” (which also has “1D” in the name), several studies show that the ingredient of seized blotter paper printed “1D‐LSD” was actually 1‐(2‐thienoyl)‐LSD (1T‐LSD). However, there are no reports of seizures of 1‐(1,2‐dimethylcyclobutanecarbonyl)‐LSD (1D‐LSD). Accordingly, it was considered that all or at least a certain percentage of “1D‐AL‐LAD (1‐(1,2‐dimethylcyclobutanecarbonyl)‐6‐allyl‐nor‐LSD)” is actually 1‐(2‐thienoyl)‐6‐allyl‐nor‐LSD (1T‐AL‐LAD). This compound is handled by a number of distributors as of April 2024; therefore, it should be characterized in advance if seized. In this study, 1T‐AL‐LAD was synthesized and characterized using nuclear magnetic resonance spectroscopy, Fourier transform‐infrared spectroscopy, liquid chromatography/high‐resolution mass spectrometry (LC/HRMS) and gas chromatography/MS (GC/MS). This compound was easily distinguished from previously reported lysergamides. There were some differences in the detectability of 1T‐AL‐LAD compared with other lysergamides using GC/MS and the fragmentation patterns in LC/HRMS. These differences can be reasonably explained. This information will be of help to determine this substance in seized materials should it emerge on the market.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lysergic Acid DiethylamideIllicit DrugsHallucinogensGas Chromatography-Mass SpectrometryMagnetic Resonance Spectroscopy

Stichwörter der Autor:innen

1D‐AL‐LADchemical synthesislysergamidenew psychoactive substances

Substanzen

Lysergic Acid DiethylamideIllicit DrugsHallucinogens

Autor:innen und Institutionen

  • Third Department of Forensic Science, National Research Institute of Police Science, Kashiwa, Chiba, Japan.

ORCID-Profile: Yuki Okada, Hiroki Segawa, Kenji Kuwayama, Kenji Tsujikawa, Tatsuyuki Kanamori

Förderung

  • Japan Society for the Promotion of Science

Zitieren

APA

Okada, Y., Segawa, H., Yamamuro, T., Kuwayama, K., Tsujikawa, K., Kanamori, T., & Iwata, Y. T. (2025). Synthesis and analytical characterization of 1‐(2‐thienoyl)‐6‐allyl‐nor‐ d ‐lysergic acid diethylamide (1T‐AL‐LAD). Drug Testing and Analysis. https://doi.org/10.1002/dta.3747

Vancouver

Okada Y, Segawa H, Yamamuro T, Kuwayama K, Tsujikawa K, Kanamori T, et al. Synthesis and analytical characterization of 1‐(2‐thienoyl)‐6‐allyl‐nor‐ d ‐lysergic acid diethylamide (1T‐AL‐LAD). Drug Testing and Analysis. 2025. doi:10.1002/dta.3747

BibTeX
@article{Okada2025,
  author = {Okada, Yuki and Segawa, Hiroki and Yamamuro, Tadashi and Kuwayama, Kenji and Tsujikawa, Kenji and Kanamori, Tatsuyuki and Iwata, Yuko T},
  title = {Synthesis and analytical characterization of 1‐(2‐thienoyl)‐6‐allyl‐nor‐ d ‐lysergic acid diethylamide (1T‐AL‐LAD)},
  journal = {Drug Testing and Analysis},
  year = {2025},
  doi = {10.1002/dta.3747}
}
Kostenlos starten →